Anticancer Activity of Novel Trifluoromethylquinoline Derivatives Designed to Target the Tubulin Colchicine Binding Site
Chemistry & Biodiversity · 2026-06 · 23 (6)
DOI: 10.1002/cbdv.71420 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 15.06.2026. Verfasst von Xiangkai Kong und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine & School of Pharmaceutical Sciences, Guizh…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Tubulin, Colchicine, Tubulin Modulators. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guizhou Provincial Major Scientific and Technological Program, High-level Innovative Talents Fund of Guizhou Province.
Abstract (Originalsprache)
Colchicine binding site inhibitors (CBSIs) have developed rapidly in recent years as antitumor agents. Currently, no inhibitors of this specific class are approved for clinical use. In this study, a series of novel 2‐trifluoromethyl‐4‐aminoquinoline derivatives were designed, synthesized, and evaluated for their antiproliferative activity. Among them, compound 8a was the most potent against LNCaP cells with an IC 50 value of 1 nM. Mechanistic studies demonstrated that 8a disrupted tubulin polymerization by binding to the colchicine site of tubulin. Meanwhile, 8a could induce cell apoptosis. Molecular docking indicated that 8a could bind well to the amino acid residues in microtubule protein cavities. Overall, these findings suggested that compound 8a could be a promising antitumor agent targeting the tubulin colchicine binding site.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine & School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, China.
- Guizhou Provincial Key Laboratory of Innovation and Manufacturing for Pharmaceuticals, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guiyang, P.R. China.
- State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, School of Pharmaceutical Sciences, Natural Products Research Center of Guizhou Province, Guizhou Medical Univer…
Förderung
- National Natural Science Foundation of China
- Guizhou Provincial Major Scientific and Technological Program
- High-level Innovative Talents Fund of Guizhou Province
- Department of Science and Technology of Guizhou Province
- the Project of Health Commission of Guizhou Province
- Guizhou Medical University
- Guizhou Provincial Education Department Youth Science and Technology Talent Development Project
- Guizhou Provincial Science and Technology Department
Zitieren
APA
Kong, X., Su, Y., He, S., Tang, L., & Meng, X. (2026). Anticancer Activity of Novel Trifluoromethylquinoline Derivatives Designed to Target the Tubulin Colchicine Binding Site. Chemistry & Biodiversity, 23(6). https://doi.org/10.1002/cbdv.71420
Vancouver
Kong X, Su Y, He S, Tang L, Meng X. Anticancer Activity of Novel Trifluoromethylquinoline Derivatives Designed to Target the Tubulin Colchicine Binding Site. Chemistry & Biodiversity. 2026;23(6). doi:10.1002/cbdv.71420
BibTeX
@article{Kong2026,
author = {Kong, Xiangkai and Su, Yu and He, Siyu and Tang, Lei and Meng, Xueling},
title = {Anticancer Activity of Novel Trifluoromethylquinoline Derivatives Designed to Target the Tubulin Colchicine Binding Site},
journal = {Chemistry & Biodiversity},
year = {2026},
volume = {23},
number = {6},
doi = {10.1002/cbdv.71420}
}
EUVIMED